Dow Jones
38.460,92 -42,77 (-0,11%) Nasdaq
15.712,75 +16,11 (+0,10%) Nikkei 225
38.003,29 -456,79 (-1,19%) EUR/USD
1,0703 +0,0002 (+0,02%) Bitcoin EUR
60.235,77 -2.103,46 (-3,37%) CMC Crypto 200
1.394,81 -29,29 (-2,06%)
AxoGen, Inc. (0HKD.L)
| Chiusura precedente | 6,99 |
| Aperto | 0,00 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 0,00 - 0,00 |
| Intervallo di 52 settimane | |
| Volume | |
| Media Volume | 424 |
| Capitalizzazione | 2,594M |
| Beta (5 anni mensile) | 1,02 |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -0,77 |
| Prossima data utili | 07 mag 2024 - 13 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
GlobeNewswireAxogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™
ALACHUA, Fla. and TAMPA, Fla., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the full launch of Axoguard HA+ Nerve Protector. “Axoguard HA+ is an important extension of our nerve protection platform,” commented Karen Zaderej, Axogen's Chairman, CEO, and President. “The release of Axoguard HA+ expands opportunities for surgeons to treat a wider range of nerve
- GlobeNewswire
Axogen to Participate at Upcoming Investor Conferences
ALACHUA and TAMPA, Fla., Aug. 31, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, Chairman, Chief Executive Officer, and President, will participate in two investor conferences in September. Zaderej will present at the H.C. Wainwright 25th Annual Global Investment Conference in New York, NY on Monday, September 11, 2023 at 8:30 a.m. ET.Zaderej will pa
- GlobeNewswire
Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio
ALACHUA, Fla. and TAMPA, Fla., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the successful first week of processing for Avance Nerve Graft at the newly opened Axogen Processing Center (APC), in Dayton, Ohio. “We are pleased to mark this significant milestone as we begin processing Avance Nerve Graft in our new APC facility,” commented Karen Zaderej, Axogen's
